ArticleDiabetes, obesity & metabolism2026

Semaglutide and Resmetirom in Patients With Metabolic Dysfunction-Associated Steatohepatitis and Fibrosis: An Exploratory Indirect Comparison.

Alessandro Mantovani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.